Here we determined TWIST-1 expression in patients with AML, ALL and CML and provided the first evidence that TWIST-1 was highly expressed in patients with AML, whereas no significant difference was observed between ALL patients and controls. This evidence concerns the gene TWIST1 and chronic myelogenous leukemia, BCR-ABL1 positive.